Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)
China · Delayed Price · Currency is CNY 35.60
+1.87 (5.54%)
Jun 23, 2026, 3:04 PM CST
SHE:300878 Market Cap
SHE:300878 has a market cap or net worth of 4.79 billion as of June 23, 2026. Its market cap has increased by 119.74% in one year.
Market Cap
4.79B
Enterprise Value
4.85B
Revenue
225.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.60
Market Cap Chart
Since August 24, 2020, SHE:300878's market cap has decreased from 6.52B to 4.79B, a decrease of -26.50%. That is a compound annual growth rate of -5.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 5.06B | 39.55% |
| Dec 31, 2025 | 3.62B | 69.28% |
| Dec 31, 2024 | 2.14B | -41.72% |
| Dec 29, 2023 | 3.67B | 2.30% |
| Dec 30, 2022 | 3.59B | -15.42% |
| Dec 31, 2021 | 4.25B | 4.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Weiguang Biological Products | 5.03B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.82B |
| PharmaResources (Shanghai) | 4.76B |
| Wuhan Hvsen Biotechnology | 4.69B |
| Beijing Konruns Pharmaceutical | 4.64B |
| R&G PharmaStudies | 4.52B |
| Jiangsu Bioperfectus Technologies | 4.14B |
| Beijing Scitop Bio-tech | 4.11B |